IP1 - Aimed at finding and trialing an imaging technique, like mammograms for breast cancer, that could be offered as a screening test for prostate cancer.

IP2 - Investigating treating the prostate and other cancer deposits in men with already advanced cancer in a bid to halt further spread.

IP3 - A pilot study exploring a trial design (cohort-multiple RCT) that has not previously been utilised in the field of prostate cancer research.

IP4 - A comparison study between whole gland and focal treatment in new localised prostate cancer, with the aim to directly compare effectiveness.

IP5 - Aimed at understanding men’s preferences and decision making in regard to current and new treatments for advanced prostate cancer.

IP6 - A validation study of a new AI tool that is reported to be able to detect and rule out prostate cancer on high resolution scanned pathology slides.

IP7 - An evaluation of Biparametric MRI and Image Fusion targeted biopsy.

IP8 - Assessing the accuracy of digital fluorescence confocal microscopy for assessment of surgical margins in radical prostatectomy specimens.

IP9 - A randomised control trial of regular MRI scans compared to standard of care in patients with prostate cancer managed using active surveillance.

IP10 - A comparison of portable MRI and TRUS-Fusion prostate biopsy to assess the accuracy of prostate cancer detection.

IP11 - Aiming to understand how the primary tumour in the prostate, and the treatment of this, can affect secondary tumours at other sites.

IP13 - A randomised control trial of PSMA PET imaging in directing treatment for high risk prostate cancer.